Seeing if watchful waiting helps after miscarriage or delivery
Part of Women’s health & pregnancy clinical trials.
This study looks at whether managing a condition where pregnancy tissue remains in the womb (called retained products of conception) without immediate surgery is safe and effective. It might be an option for people who are stable and want to avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a miscarriage or gave birth in the last 8 weeks
- You are willing to try managing the problem without surgery first
- You are not having very heavy bleeding that needs emergency surgery
- You do not have a serious infection or fever
- You do not have severe heart, liver, or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an injected gel helps prevent scar tissue from forming again after a procedure to remove leftover pregnancy tissue inside the uterus. If you qualify, you may receive the gel as part of a randomized trial to see if it lowers the chance of re-adhesions (re-forming tissue sticking).
This trial studies the best way to remove leftover pregnancy tissue after a first-trimester miscarriage. It compares approaches guided by a camera procedure in the uterus to see which helps most, especially for people who want to get pregnant again soon.
This study compares two outpatient procedures—hysteroscopy and suction—to remove retained pregnancy tissue after a miscarriage in the first 3 months. The goal is to find which method works best and is safest for people who choose surgical treatment.
This study follows patients with retained products of conception (tissue left in the uterus after a pregnancy) to see how they are managed in real-world medical practice. You may join if an ultrasound shows a tissue area of at least half a centimeter.
This trial tests if injecting vasopressin into the cervix reduces bleeding during surgery to remove leftover pregnancy tissue after a miscarriage, abortion, or childbirth. It may help make the procedure safer.
This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.
Hear when a new Retained Products of Conception trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.